Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction

This publication has 27 references indexed in Scilit:

• Endothelial cell injury in cardiovascular surgery: The pathophysiology of vasomotor dysfunction
  The Annals of Thoracic Surgery, 1996
• Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and l-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass
  The Journal of Thoracic and Cardiovascular Surgery, 1996
• Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.
  Journal of Clinical Investigation, 1995
• C5a-induced expression of P-selectin in endothelial cells.
  Journal of Clinical Investigation, 1994
• Complement and neutrophil activation during cardiopulmonary bypass: A study in the complement-deficient dog
  The Annals of Thoracic Surgery, 1994
• Inflammatory response to cardiopulmonary bypass
  The Annals of Thoracic Surgery, 1993
• Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis
  Science, 1990
• Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family.
  Journal of Clinical Investigation, 1989
• Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo.
  Circulation Research, 1988
• Effects of Protamine Administration after Cardiopulmonary Bypass on Complement, Blood Elements, and the Hemodynamic State
  The Annals of Thoracic Surgery, 1986